منابع

1- Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. 2020;5(4):536-44.2- Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virology Journal. 2019;16(1):69.

3- Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The Lancet. 2020;395(10223):470-3.

4- Chen J. Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses. Microbes and Infection. 2020;22(2):69-71.

5- Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection. 2020.

6- Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine. 2020;46(4):586-90.

7-Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020:2020.01.26.919985.

8- Chu H, Chan JF-W, Yuen TT-T, Shuai H, Yuan S, Wang Y, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. The Lancet Microbe.

9- Tse EG, Korsik M, Todd MH. The past, present and future of anti-malarial medicines. Malaria journal. 2019;18(1):93.

10- Zheng M, Song L. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cellular & molecular immunology. 2020.

11- Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, et al. COVID-19: combining antiviral and anti-inflammatory treatments. The Lancet Infectious diseases. 2020;20(4):400-2.

1- Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. The Cochrane database of systematic reviews. 2012(3):Cd006206.2- Mehrbod P, Amini E, Tavassoti-Kheiri M. Antiviral activity of garlic extract on Influenza virus. Iranian Journal of Virology. 2009;3(1):19-23.

3- Xie Y, Chen Y, Guo Y, Huang Y, Zhu B. Allicin and Glycyrrhizic Acid Display Antiviral Activity Against Latent and Lytic Kaposi Sarcoma-associated Herpesvirus. Infectious Microbes & Diseases. 2020;2(1).

4- Weber ND, Andersen DO, North JA, Murray BK, Lawson LD, Hughes BG. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta medica. 1992;58(5):417-23.

5- Leontiev R, Hohaus N, Jacob C, Gruhlke MCH, Slusarenko AJ. A Comparison of the Antibacterial and Antifungal Activities of Thiosulfinate Analogues of Allicin. Scientific Reports. 2018;8 (1),6763